生物活性
A-674563是一种B/Akt抑制剂,IC50为14 nM,并且还显示出对PKA和CDK2的抑制活性,IC50分别为16和46 nM。
Targets
Target | Value |
Akt1 | ki: 11nM |
PKA | ki: 16nM |
CDK2 | ki: 46nM |
GSK-3β | ki: 110nM |
ERK2 | ki: 260nM |
PKCδ | ki: 360nM |
RSK2 | ki: 580nM |
MAPK-AP2 | ki: 1.1μM |
PKCγ | ki: 1.2μM |
FLT1 | ki: >2.2μM |
Chk1 | ki: 2.6μM |
KDR | ki: >3.7μM |
CK2 | ki: 5.4μM |
c-Kit | ki: >5.8μM |
Src | ki: 13μM |
PDK-1 | ki: >20μM |
化学数据
目录号 | A11034 |
作用机制 | Inhibitor (抑制剂) |
M. Wt | 358.4 |
Formula | C22H22N4O |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for36 months. In solution, store at -20ºC and use within3 monthsto prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
CAS No. | 552325-73-2 |
Synonyms | A674563 |
SMILES | CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CC=CC=C4)N |
溶解度
In vitro (25°C) | DMSO | 71 mg/mL (198.08 mM) |
Water | 71 mg/mL (198.08 mM) |
Ethanol | 18 mg/mL (50.21 mM) |
In vivo | Saline | 28 mg/mL |
*<1 mg/ml means slightly soluble or insoluble. *Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
储备液配制
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
0.1 mM | 27.9 mL | 139.51 mL | 279.02 mL |
0.5 mM | 5.58 mL | 27.9 mL | 55.8 mL |
1 mM | 2.79 mL | 13.95 mL | 27.9 mL |
5 mM | 0.56 mL | 2.79 mL | 5.58 mL |
*The above data is based on the productmolecular weight 358.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.